We are live on
!
Find out more
DJSG
D.J. St. Germain Portfolio holdings
AUM
$2.78B
1-Year Est. Return
23.87%
This Fund
S&P 500
This Quarter
Est. Return
+3.07%
1 Year Est. Return
+23.87%
3 Year Est. Return
+65.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$653M
AUM Growth
-$28.9M
(-4.2%)
Cap. Flow
-$46.4M
Cap. Flow
% of AUM
-7.09%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
110
New
5
Increased
13
Reduced
75
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$2.99M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$927K |
| 3 |
Ford
F
|
+$705K |
| 4 |
AT&T
T
|
+$389K |
| 5 |
Freeport-McMoran
FCX
|
+$311K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.96M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$7.5M |
| 3 |
Vanguard Total Bond Market
BND
|
+$2.71M |
| 4 |
iShares MBS ETF
MBB
|
+$2.02M |
| 5 |
Corning
GLW
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.34% |
| 2 | Healthcare | 13.06% |
| 3 | Energy | 12.92% |
| 4 | Financials | 11.32% |
| 5 | Industrials | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCI
101
Barings Corporate Investors
MCI
$340M
| $201K | 0.03% |
13,236
| – | – |
|
|
RAD
102
DELISTED
Rite Aid Corporation
RAD
| $160K | 0.02% |
1,276
| – | – |
|
|
WAVX
103
DELISTED
WAVE SYS CORP CL A NEW COM STK (DE)
WAVX
| $9K | ﹤0.01% |
+1,000
| New | +$9.63K |
|
104
SPDR Gold Trust
GLD
$131B
| – | – |
-2,463
| Closed | -$286K |
|
|
105
iShares Biotechnology ETF
IBB
$9.31B
| – | – |
-118,452
| Closed | -$8.96M |
|
|
KMR
106
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
| $0 | ﹤0.01% |
39,462
-702
| -2% | -$48.8K |
|
Similar funds
GM
EGA
TMAM
SAM
LGP
MC
HP
AGA
D.J. St. Germain's Q1 2014 Portfolio in Review
As of Q1 2014, D.J. St. Germain held 110 positions worth $653M, down 4.2% from $682M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
D.J. St. Germain withdrew a net $46.4M in Q1 2014, closing 3 positions and reducing 75 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $8.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Energy.
Against the trend, D.J. St. Germain opened a new position in Target worth $3.05M.
- D.J. St. Germain's largest Q1 2014 buy was Target: 50,470 shares worth $3.05M.
- D.J. St. Germain added most to Vanguard FTSE Emerging Markets ETF in Q1 2014, an estimated $927K increase.
- D.J. St. Germain's biggest Q1 2014 reduction was Charles Schwab, cutting an estimated $7.5M.
- D.J. St. Germain fully exited iShares Biotechnology ETF in Q1 2014, selling an estimated $8.96M.
- D.J. St. Germain's ten largest holdings make up 33% of its $653M portfolio in Q1 2014.
- D.J. St. Germain opened 5 new positions and closed 3 in Q1 2014.
- D.J. St. Germain's portfolio value fell 4.2% quarter-over-quarter to $653M.
Based on D.J. St. Germain's 13F filing for Q1 2014, filed 10 Apr 2014.